The Business Research Company
The Business Research Company’s Age-Related Macular Degeneration Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
With vision loss emerging as one of the most pressing public health challenges of an aging world, the age-related macular degeneration market is drawing serious attention from investors, clinicians, and policymakers alike. As the global population ages and the incidence of this sight-threatening condition climbs, the sector is positioned for sustained momentum. Here’s a closer examination of the market’s trajectory, the forces behind its expansion, and what lies ahead for this critical area of healthcare.
Also worth a look: Amniotic products market heads to $1.65B by 2030 as surgery demand climbs and OffiGo’s new desk guide: storage layout beats drawer count.
Age-Related Macular Degeneration Market Size and Growth Outlook
The age-related macular degeneration (AMD) market has seen notable growth over recent years, and that momentum shows no signs of slowing. Valued at $10.67 billion in 2025, the market is forecast to climb to $11.46 billion in 2026—a compound annual growth rate (CAGR) of 7.5%. That uptick reflects a convergence of factors: a rapidly aging global population, a rising tally of AMD diagnoses, historically limited early-stage treatment options, heightened public awareness around eye health, and the continued build-out of hospitals and ophthalmology clinics worldwide. By 2030, projections put the market at $15.42 billion, growing at a CAGR of 7.7%. The longer-term outlook is bolstered by the emergence of next-generation anti-VEGF therapies, deeper investment in ophthalmology research, the rise of specialty and online pharmacy channels, growing use of combination treatment regimens, and a shift toward personalized medicine approaches.
Download a free sample of the age-related macular degeneration market report:
https://thebusinessresearchcompany.com/sample_request?id=37131527&type=smp&name=Age-Related%20Macular%20Degeneration%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR
Understanding Age-Related Macular Degeneration and Its Treatment
Age-related macular degeneration is a progressive condition that targets the macula—the central portion of the retina responsible for sharp, straight-ahead vision. Over time, the macula degrades, causing central vision to blur or disappear while peripheral sight often remains intact. Managing the disease typically involves routine eye examinations, lifestyle modifications, and nutritional supplements formulated to slow the deterioration process.
The Growing Impact of AMD on Market Expansion
The single most powerful driver behind the AMD market’s growth is the disease itself. As prevalence climbs, so does the urgency for effective interventions that can curb vision loss severity. In February 2023, Optimaxa, a UK-based laser eye treatment firm, reported that AMD already affects 196 million people globally—a figure expected to swell to 288 million by 2040, or roughly 8.7 percent of the world’s population. That stark trajectory is fueling demand for innovative therapies and accelerating market expansion across the board.
View the full age-related macular degeneration market report:
https://thebusinessresearchcompany.com/report/age-related-macular-degeneration-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR
Regional Perspectives in the Age-Related Macular Degeneration Market
North America dominated the global AMD market in 2025, supported by mature healthcare systems and early adoption of cutting-edge treatments. Yet the fastest growth is expected to come from Asia-Pacific over the forecast window, as healthcare spending rises and disease awareness spreads. The report spans all major regions—Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa—offering a full global perspective.
The 2026 edition of these market reports introduces expanded strategic tools, including market attractiveness scoring, total addressable market (TAM) analysis, company scoring matrices with graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology and future trend assessments, plus refreshed visuals throughout.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Why it matters: As AMD cases climb toward 288 million by 2040, the market’s projected growth signals not just commercial opportunity but a mounting healthcare imperative. Investment in advanced therapies and broader awareness will be critical to mitigating the burden of vision loss in an aging population.
